Kintara Therapeutics Inc (NASDAQ:KTRA)

0.8686
Delayed Data
As of Oct 15
 -0.0366 / -4.04%
Today’s Change
0.74
Today|||52-Week Range
3.35
-32.14%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Kintara Therapeutics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +475.64% increase from the last price of 0.87.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Kintara Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$0.00
Reporting Date
Nov 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 31.75%
 
 
 
 
 
 
Growthannually 64.75%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.